{"title":"由重症监护室评估的肿瘤患者。3 个月死亡率的预测因素","authors":"","doi":"10.1016/j.acci.2024.01.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To understand the clinical-epidemiological profile of patients with solid organ tumors who are evaluated by intensive care physicians to determine their admission to the ICU or not.</p></div><div><h3>Materials and methods</h3><p>Prospective observational study in the ICU of a tertiary hospital. The study was approved by the Research Ethics Committee (CEI) of Cantabria. Patients over 18 years of age with a solid organ tumor, for whom an assessment was requested by the intensive medicine team for ICU admission, were included. The study included both patients who were admitted and those whose admission was declined. Informed consent was obtained from all patients for inclusion in the registry. Clinical data were reviewed, and patients were followed up 3 months after ICU evaluation.</p></div><div><h3>Results</h3><p>215 patients were evaluated, of which 173 were admitted to the ICU. The main factors associated with mortality at 3 months after ICU evaluation were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score<!--> <!-->>2 or Karnofsky <<!--> <!-->70.</p></div><div><h3>Conclusions</h3><p>The main factors associated with mortality at 3 months after being evaluated by ICU were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score<!--> <!-->>2 or Karnofsky <<!--> <!-->70.</p></div>","PeriodicalId":100016,"journal":{"name":"Acta Colombiana de Cuidado Intensivo","volume":"24 3","pages":"Pages 198-207"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pacientes oncológicos valorados por la Unidad de Cuidados Intensivos. Factores predictores de mortalidad a 3 meses\",\"authors\":\"\",\"doi\":\"10.1016/j.acci.2024.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To understand the clinical-epidemiological profile of patients with solid organ tumors who are evaluated by intensive care physicians to determine their admission to the ICU or not.</p></div><div><h3>Materials and methods</h3><p>Prospective observational study in the ICU of a tertiary hospital. The study was approved by the Research Ethics Committee (CEI) of Cantabria. Patients over 18 years of age with a solid organ tumor, for whom an assessment was requested by the intensive medicine team for ICU admission, were included. The study included both patients who were admitted and those whose admission was declined. Informed consent was obtained from all patients for inclusion in the registry. Clinical data were reviewed, and patients were followed up 3 months after ICU evaluation.</p></div><div><h3>Results</h3><p>215 patients were evaluated, of which 173 were admitted to the ICU. The main factors associated with mortality at 3 months after ICU evaluation were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score<!--> <!-->>2 or Karnofsky <<!--> <!-->70.</p></div><div><h3>Conclusions</h3><p>The main factors associated with mortality at 3 months after being evaluated by ICU were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score<!--> <!-->>2 or Karnofsky <<!--> <!-->70.</p></div>\",\"PeriodicalId\":100016,\"journal\":{\"name\":\"Acta Colombiana de Cuidado Intensivo\",\"volume\":\"24 3\",\"pages\":\"Pages 198-207\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Colombiana de Cuidado Intensivo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0122726224000041\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Colombiana de Cuidado Intensivo","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0122726224000041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pacientes oncológicos valorados por la Unidad de Cuidados Intensivos. Factores predictores de mortalidad a 3 meses
Objective
To understand the clinical-epidemiological profile of patients with solid organ tumors who are evaluated by intensive care physicians to determine their admission to the ICU or not.
Materials and methods
Prospective observational study in the ICU of a tertiary hospital. The study was approved by the Research Ethics Committee (CEI) of Cantabria. Patients over 18 years of age with a solid organ tumor, for whom an assessment was requested by the intensive medicine team for ICU admission, were included. The study included both patients who were admitted and those whose admission was declined. Informed consent was obtained from all patients for inclusion in the registry. Clinical data were reviewed, and patients were followed up 3 months after ICU evaluation.
Results
215 patients were evaluated, of which 173 were admitted to the ICU. The main factors associated with mortality at 3 months after ICU evaluation were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score >2 or Karnofsky < 70.
Conclusions
The main factors associated with mortality at 3 months after being evaluated by ICU were the type of tumor, the status of the tumor, the presence of hypertriglyceridemia, and a functional status upon admission with an ECOG score >2 or Karnofsky < 70.